Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,095 | 54,135 | 35,210 | 56,064 | 58,651 |
| Marketable Securities | 47,051 | 15,356 | 15,528 | N/A | N/A |
| Receivables | 200 | 595 | 658 | 386 | 315 |
| TOTAL | $65,675 | $71,350 | $53,392 | $58,268 | $60,866 |
| Non-Current Assets | |||||
| PPE Net | 1,404 | 1,542 | 1,663 | 1,790 | 1,989 |
| Other Non-Current Assets | 408 | 479 | 632 | 1,094 | 1,094 |
| TOTAL | $1,812 | $2,021 | $2,295 | $2,884 | $3,083 |
| Total Assets | $67,487 | $73,371 | $55,687 | $61,152 | $63,949 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,586 | 3,976 | 2,929 | 2,872 | 2,625 |
| TOTAL | $3,586 | $3,976 | $2,929 | $2,872 | $2,782 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 157 |
| TOTAL | $N/A | $86 | $101 | $117 | $133 |
| Total Liabilities | $3,586 | $4,062 | $3,030 | $2,989 | $2,915 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,936 | N/A | 14,426 | 14,404 | 14,402 |
| Common Shares | 173,246 | 172,886 | 148,867 | 148,728 | 148,634 |
| Retained earnings | -142,681 | -136,704 | -128,972 | -122,956 | -119,693 |
| Other shareholders' equity | -990 | -990 | -990 | -990 | -990 |
| TOTAL | $63,901 | $69,309 | $52,657 | $58,163 | $61,034 |
| Total Liabilities And Equity | $67,487 | $73,371 | $55,687 | $61,152 | $63,949 |